Alaunos Therapeutics Inc. (TCRT)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q4 2020 | |||||
| ≡ | Bill Miller - Miller Value Partners | Add 0.65% | 5,377 | 0.01 | |
| Q1 2020 | |||||
| ≡ | Bill Miller - Miller Value Partners | Add 0.96% | 8,186 | 0.02 | |
| Q3 2019 | |||||
| ≡ | Bill Miller - Miller Value Partners | Add 40.52% | 249,599 | 0.65 | |
| Q4 2018 | |||||
| ≡ | Bill Miller - Miller Value Partners | Add 92.31% | 296,476 | 0.36 | |
| Q4 2017 | |||||
| ≡ | Bill Miller - Miller Value Partners | Add 4.65% | 15,059 | 0.04 | |
| Q2 2017 | |||||
| ≡ | Bill Miller - Miller Value Partners | Add 0.02% | 75 | 0.00 | |
| Q1 2017 | |||||
| ≡ | Bill Miller - Miller Value Partners | Add 0.50% | 1,640 | 0.01 | |
| Q2 2015 | |||||
| ≡ | Daniel Loeb - Third Point | Buy | 130,000 | 0.23 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.